oral glutathione skin whitening Brightener™ with Ceramosides® Veg Capsules Oral vs. Topical Glutathione by

PMID: 39067875 | doi:10.1136/jitc-2024-009281 Cant C et al

For inclusion in the Extension Phase studies, subjects must have completed the Main Phase with FBG 150 mg/dL

Approved Uses and Current Clinical Evidence in the UK Neither cagrilintide nor retatrutide is licensed by the MHRA or EMA

A.AlKassasbehR.AbbasM

Important research considerations include: Strong Word: Precision Maintaining precise preparation procedures helps support consistency during research activities

This product is supplied as a 10mg lyophilised research material intended exclusively for controlled laboratory research, analytical testing and scientific investigation